Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center, shared a post on X:
“The Lustgarten Foundation Honors Revolution Medicines for Transformative Research in Pancreatic Cancer.
The “tri-complex” collaboration between Lustgarten Foundation, Break Through Cancer and RevMed on RAS inhibitor trials (via Team Conquering KRAS) has been spectacular.”